Platinum Investment Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-1,380,618
Closed -$21.8M – 156
2023
Q4
$21.8M Sell
1,380,618
-955,374
-41% -$9.2M 0.88% 25
2023
Q3
$18.1M Buy
2,335,992
+642
+0% +$5.32K 0.71% 26
2023
Q2
$23.2M Sell
2,335,350
-114,552
-5% -$917K 0.8% 29
2023
Q1
$14.2M Buy
2,449,902
+200,191
+9% +$1.73M 0.49% 35
2022
Q4
$17.9M Buy
2,249,711
+365,943
+19% +$1.57M 0.68% 28
2022
Q3
$5.95M Buy
1,883,768
+249,764
+15% +$1.56M 0.25% 47
2022
Q2
$9.36M Buy
1,634,004
+155,271
+11% +$1.21M 0.35% 43
2022
Q1
$10.4M Buy
1,478,733
+662,367
+81% +$10.4M 0.32% 44
2021
Q4
$18.7M Buy
816,366
+29,791
+4% +$769K 0.52% 35
2021
Q3
$23.3M Buy
+786,575
New +$26.7M 0.66% 27

Platinum Investment Management's ICVX Position: Q1 2024 in Review

Platinum Investment Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 1,380,618 shares — an estimated $21.8M sold.

Platinum Investment Management first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $23.3M in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Platinum Investment Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Platinum Investment Management sold 1,380,618 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $21.8M.
  • Platinum Investment Management first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Platinum Investment Management's Icosavax, Inc. Common Stock position peaked at $23.3M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Platinum Investment Management's 13F filing for Q1 2024, filed 13 May 2024.